These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7563166)

  • 1. New drug screen assay uses fewer mice, while cutting costs.
    Anderson LF
    J Natl Cancer Inst; 1995 Aug; 87(16):1213-4. PubMed ID: 7563166
    [No Abstract]   [Full Text] [Related]  

  • 2. [New approaches in experimental cancerology: in search of therapeutic models].
    Guilbaud N; Kraus-Berthier L; Meyer-Losic F; Pierré A; Hickman J
    Bull Cancer; 2001 Jan; 88(1):75-84. PubMed ID: 11182656
    [No Abstract]   [Full Text] [Related]  

  • 3. The mighty mouse: genetically engineered mouse models in cancer drug development.
    Sharpless NE; Depinho RA
    Nat Rev Drug Discov; 2006 Sep; 5(9):741-54. PubMed ID: 16915232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ways to overcome the contradictions between the experimental and clinical chemotherapy of tumors].
    Syrkin AB
    Vopr Onkol; 1990; 36(6):740-4. PubMed ID: 2378096
    [No Abstract]   [Full Text] [Related]  

  • 5. Strategy for developing transgenic assays for screening antineoplastic drugs that affect tubulin polymerization.
    Porter GM; Armstrong L; Nielsen LL
    Lab Anim Sci; 1995 Apr; 45(2):145-50. PubMed ID: 7603014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results of random screening of antineoplastic agents in Japan. The sixth report].
    Gan To Kagaku Ryoho; 1994 Jul; 21(9):1301-556. PubMed ID: 8067784
    [No Abstract]   [Full Text] [Related]  

  • 7. Testing therapeutic potency of anticancer drugs in animal studies: a commentary.
    Den Otter W; Steerenberg PA; Van der Laan JW
    Regul Toxicol Pharmacol; 2002 Apr; 35(2 Pt 1):266-72. PubMed ID: 12052010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are syngeneic mouse tumor models still valuable experimental models in the field of anti-cancer drug discovery?
    Darro F; Decaestecker C; Gaussin JF; Mortier S; Van Ginckel R; Kiss R
    Int J Oncol; 2005 Sep; 27(3):607-16. PubMed ID: 16077908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro drug resistance versus chemosensitivity: two sides of different coins.
    Fruehauf JP; Alberts DS
    J Clin Oncol; 2005 May; 23(15):3641-3; author reply 3646-8. PubMed ID: 15908686
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthesis and photosensitizing efficacy of isomerically pure bacteriopurpurinimides.
    Chen Y; Sumlin A; Morgan J; Gryshuk A; Oseroff A; Henderson BW; Dougherty TJ; Pandey RK
    J Med Chem; 2004 Sep; 47(20):4814-7. PubMed ID: 15369384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term assay (radiolabeled DNA-precursor uptake method) in gynecologic malignancies. Methodology and results.
    Petru E; Kaufmann M
    Contrib Gynecol Obstet; 1994; 19():30-8. PubMed ID: 7995051
    [No Abstract]   [Full Text] [Related]  

  • 12. [An experimental study of the antitumor properties of olipifat].
    Filov VA; Reztsova VV; Kil'maeva NE; Petukhov DV; Pinchuk BT
    Vopr Onkol; 2000; 46(3):332-6. PubMed ID: 10976281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemosensitivity testing.
    Letwin R
    Clin J Oncol Nurs; 2001; 5(5):195-200. PubMed ID: 11899765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preclinical studies for development of anti-cancer drugs: current and historical status and problems].
    Okabe M; Kobayashi S; Hirata T; Nakano H; Ikegami J; Inoue K; Komuro T
    Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():302-9. PubMed ID: 7986108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benzethonium chloride: a novel anticancer agent identified by using a cell-based small-molecule screen.
    Yip KW; Mao X; Au PY; Hedley DW; Chow S; Dalili S; Mocanu JD; Bastianutto C; Schimmer A; Liu FF
    Clin Cancer Res; 2006 Sep; 12(18):5557-69. PubMed ID: 17000693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The potential use of an extract of aspen bark for enhancing the efficacy of specific treatment methods in experimental malignant neoplasms].
    Razina TG; Krylova SG; Zueva EP; Amosova EN; Turetskova VF
    Eksp Klin Farmakol; 1998; 61(6):42-4. PubMed ID: 9929816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of 17DMAG, a geldanamycin derivative, in murine acute myeloid leukemia.
    Panarsky R; Reichert F; Ben-Ishay Z
    Acta Haematol; 2009; 121(1):32-6. PubMed ID: 19332984
    [No Abstract]   [Full Text] [Related]  

  • 18. [The use of induced and spontaneous animal neoplasms in the experimental therapy of tumors].
    Anikin IV; Pliss GB; Vlasov NN
    Vopr Onkol; 1993; 39(4-6):161-8. PubMed ID: 7975390
    [No Abstract]   [Full Text] [Related]  

  • 19. In vivo/in vitro correlation of xenografts in nude mice and the ATP-cell viability assay.
    Perras JP; Hurst J
    Contrib Gynecol Obstet; 1994; 19():122-31. PubMed ID: 7995044
    [No Abstract]   [Full Text] [Related]  

  • 20. Advances in molecular carcinogenesis: current and future use of mouse models to screen and validate molecularly targeted anticancer drugs.
    Frijhoff AF; Conti CJ; Senderowicz AM
    Mol Carcinog; 2004 Apr; 39(4):183-94. PubMed ID: 15057870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.